Thursday, February 5, 2015

Hot Long Term Companies To Buy Right Now

Two European studies came out this week, both with interesting implications. The first study came out of Denmark and noted that chronic lower back pain may be curable with an extended regimen of antibiotics.�

Our second study may be even more important. In Germany, scientists studied 400 children and found that poor air quality is a contributor to Type 2 diabetes. It turns out that pollution creates a significant bump in insulin resistance, leading to diabetes.

Both of these studies will need larger trials to confirm the results. In this video, health-care analyst David Williamson discusses the potential impact for investors if both of these still-early results prove correct over time.�

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.�Click here now�to keep reading.

Top 5 European Companies For 2015: China Ming Yang Wind Power Group Ltd (MY)

China Ming Yang Wind Power Group Limited incorporated on February 26, 2009, is a wind turbine manufacturer in China, focusing on designing, manufacturing, selling and servicing megawatt-class wind turbines. The Company�� products consist of basic models of wind turbines, each with a rated power capacity of 1.5 megawatt (MW); wind turbines with a rated power capacity of 2.0MW, and 2.5/3.0MW SCD wind turbines. Each product type may be installed with one of three rotor blade models depending on the location and wind conditions. As of December 31, 2012, the Company had entered into sales contracts with 37 end customers to deliver 3,730 units of its wind turbines.

It cooperates with aerodyn Energiesysteme to develop its 1.5 megawatt wind turbines and share intellectual property rights. It also has obtained licenses from aerodyn Asia Co., Ltd. (aerodyn Asia) to manufacture and distribute wind turbines utilizing its super-compact drive (SCD) technology, with a rated power capacity of 6.0MW.

The Company�� customers are the Chinese state-owned power producers which include Huaneng, China Datang, Huadian, China Guodian Corporation, and China Power Investment Corporation (CPIC) or their alternative energy subsidiaries, such as China Longyuan Power Group Corporation Limited (Longyuan), a subsidiary of Guodian, and China Datang Corporation Renewable Power Co., Limited (Datang Renewable), a subsidiary of China Datang. It also sells wind turbines to regional alternative energy investment companies, regional power producers and wind farm operators in the private sector. Its facilities are located in Zhongshan, Tianjin, Jilin, Rudong, Dali and Inner Mongolia in China.

The Company produces megawatt-class, grid-connected, horizontal-axis wind turbines, equipped with a double-fed constant frequency induction generator, which is a design of the generator that enables the generator to produce electric current of a constant frequency as the shaft rotates at varying speeds causing! the generator rotor to rotate at varying speed. It offers 1.5 megawatt turbines specially designed and developed for the wind and weather conditions and power grids in China. Its 1.5 megawatt wind turbines are equipped with rotor blades with a post-installation diameter of 77.1 meters, 82.6 meters or 89.0 meters.

The Company has license rights under a license agreement from aerodyn Asia to manufacture and distribute 2.5/3.0MW SCD wind turbines and 6.0MW SCD wind turbines in China. The Company is focused on developing 3.8MW wind turbine model for larger multi-megawatt wind turbines.

The Company competes with Sinovel, Goldwind, Dongfang Electric, United Power, Vestas, Gamesa Corporacion Tecnologica S.A. and GE Energy.

Advisors' Opinion:
  • [By John Udovich]

    Small cap wind stock Broadwind Energy Inc (NASDAQ: BWEN) is up 203.7% since the start of the year, but investors might want to contain their excitement when they look closer at the�stock and�consider its�long term performance along with the performance of other wind investments like First Trust Global Wind Energy ETF (NYSEARCA: FAN) and wind energy stocks Vestas Wind Systems (OTCMKTS: VWDRY) and China Ming Yang Wind Power Group Ltd (NYSE: MY) to see whether BWEN is just blowing more hot air.

  • [By Garrett Cook]

    In trading on Tuesday, industrials shares were relative leaders, up on the day by about 0.26 percent. Top gainers in the sector included Perceptron (NASDAQ: PRCP), up 10.9 percent, China Ming Yang Wind Power Group (NYSE: MY), up 4.8 percent.

  • [By Roberto Pedone]

    Another under-$10 stock that looks ready to trigger a big breakout trade is China Ming Yang Wind Power Group (MY), a wind turbine manufacturer in China. This stock has been very hot over the last six months, with shares up sharply by 52%.

    If you take a look at the chart for China Ming Yang Wind Power Group, you'll notice that this stock has been uptrending over the last few weeks, with shares moving higher from its low of $1.91 to its intraday high of $2.59 a share. During that uptrend, shares of MY have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of MY within range of triggering a big breakout trade.

    Market players should now look for long-biased trades in MY if it manages to break out above some past overhead resistance levels at $2.58 to $2.80 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.56 million shares. If that breakout hits soon, then MY will set up to re-test or possibly take out its next major overhead resistance levels at $3.35 to its 52-week high at $3.52 a share. Any high-volume move above those levels will then give MY a chance to tag $4 a share.

    Traders can look to buy MY off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $2.30 a share, or near more support at $2.02 a share. One can also buy MY off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Travis Hoium]

    What: Shares of wind turbine maker China Ming Yang Wind Power Group (NYSE: MY  ) jumped as much as 17% after reporting earnings.

    So what: Total revenue in the first quarter was up 98% to $129.7 million, and comprehensive income was $3.8 million, or $0.03 per share. This result is a swing back to profit for the company, and it looks like demand is picking up quickly this year. �

Hot Long Term Companies To Buy Right Now: The Greenbrier Companies Inc (GBX)

The Greenbrier Companies, Inc. (Greenbrier), formerly Greenbrier Oregon, Inc., incorporated on October 24, 2005, are the designers, manufacturers and marketers of railroad freight car equipment in North America and Europe, a manufacturer and marketer of ocean-going marine barges in North America and a provider of wheel services, railcar refurbishment and parts, leasing and other services to the railroad and related transportation industries in North America. The Company operates in three business segments: Manufacturing; Wheel Services, Refurbishment & Parts; and Leasing & Services.

The Manufacturing segment, operating from facilities in the United States, Mexico and Poland, produces double-stack intermodal railcars, conventional railcars, tank cars and marine vessels.

The Wheel Services, Refurbishment & Parts segment performs wheel, axle and bearing servicing; railcar repair, refurbishment and maintenance activities; as well as production and reconditioning of a variety of parts for the railroad industry in North America. The Leasing & Services segment owns approximately 11,000 railcars and provides management services for approximately 219,000 railcars for railroads, shippers, carriers, institutional investors and other leasing and transportation companies in North America. The Company produces rail castings through an unconsolidated joint venture.

Manufacturing

The Manufacturing segment manufactures a broad array of railcar types in North America which includes railcar types other than coal cars. The primary products offered by the Company include Intermodal Railcars, Conventional Railcars, Tank Cars, European Railcar Manufacturing and Marine Vessel Fabrication. The Company manufactures a range of intermodal railcars. The important intermodal product is articulated double-stack railcar. The double-stack railcar is designed to transport containers stacked two-high on a single platform. The Company produces a range of boxcars, which are used in t! he transport of forest products, automotive, perishables, general merchandise and commodities. It also produces covered hopper cars for the grain, energy, sand and cement industries as well as gondolas for the steel and metals markets and various other conventional railcar types, including Auto-Max car.

The Company�� European manufacturing operation produces a variety of railcar (wagon) types, including a line of pressurized tank cars for liquid petroleum gas and ammonia and non-pressurized tank cars for light oil, chemicals and other products. It also produces flat cars, coil cars for the steel and metals market, coal cars for both the continental European and United Kingdom markets, gondolas, sliding wall cars and automobile transporter cars.

The Company�� Portland, manufacturing facility, located on a deep-water port on the Willamette River, includes marine vessel fabrication capabilities. It manufactures range of Jones Act ocean-going and river barges for transporting merchandise between ports within the U.S. including conventional deck barges, double-hull tank barges, railcar/deck barges, barges for aggregates and other heavy industrial products and dump barges. It focuses on the ocean-going vessels and coal carrying river barges although the facility has the capability to compete in other marine related products.

Wheel Services, Refurbishment and Parts.

Wheel Services, Railcar Repair, Refurbishment and Component Parts Manufacturing segment operates in the independent wheel services, repair, refurbishment and component parts networks in North America, operating in 39 locations. The wheel shops, operating in 12 locations, provide complete wheel services including reconditioning of wheels, axles and roller bearings in addition to new axle machining and finishing and axle downsizing. Its network of railcar repair and refurbishment shops, operating in 23 locations, performs heavy railcar repair and refurbishment, as well as routi! ne railca! r maintenance. It is engaged in the repair and refurbishment of railcars for third parties, as well as of its own leased and managed fleet. Its component parts facilities, operating in four locations, recondition railcar cushioning units, couplers, yokes, side frames, bolsters and various other parts. It also produces roofs, doors and associated parts for boxcars.

Leasing and Services

Leasing-The Company offers flexible financing programs including operating leases and by the mile leases to the customers . The Company leases are full service leases whereby the Company is responsible for maintenance and administration. Maintenance of the fleet is provided, in part, through its own facilities and engineering and technical staff.

Management Services- management services business offers a broad array of software and services that include railcar maintenance management, railcar accounting services, such as billing and revenue collection, car hire receivable and payable administration, total fleet management including railcar tracking using software, administration and railcar remarketing. The Company provide management services for a fleet of approximately 230,000 railcars for railroads, shippers, carriers, institutional investors and other leasing and transportation companies in North America.

Advisors' Opinion:
  • [By Monica Gerson]

    The Greenbrier Companies, Inc.(NYSE: GBX) shares rose 9.51% to $54.00 in pre-market trading after the company reported better-than-expected earnings for its first fiscal quarter and raised its earnings forecast for FY 2015.

  • [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

    Greenbrier Cos.(GBX) agreed to buy a 19.5% stake in South American railcar maker Amsted-Maxion Hortolandia as it moves to capitalize on growing demand in Brazil. The deal came as Greenbrier posted quarterly earnings that topped expectations and raised its outlook for the year. Shares jumped 9.7% to $54.10 premarket.

  • [By Monica Gerson]

    The Greenbrier Companies (NYSE: GBX) is projected to report its Q3 earnings at $0.74 per share on revenue of $571.07 million.

    UniFirst (NYSE: UNF) is estimated to report its Q3 earnings at $1.42 per share on revenue of $349.24 million.

Hot Long Term Companies To Buy Right Now: Cambridge Heart Inc (CAMH)

Cambridge Heart, Inc., incorporated on January 16, 1990, is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The Company's products incorporate its technology for the measurement of Microvolt T-Wave Alternans (MTWA). The MTWA Test is conducted by elevating the patient's heart rate through exercise as performed on a treadmill similar to a stress test, pharmacologic agents, or pacing with electrical pulses.

The Company's products, including its first generation HearTwave System and second generation HearTwave II System, CH 2000 Cardiac Stress Test System, MTWA original equipment manufacturer (OEM) Module (MTWA Module) and Micro-V Alternans Sensors have received 510(k) clearance from the United States Food and Drug Administration (FDA) for sale in the United States. The Company's products have also received the Conformite Europeenne (CE) mark for sale in Europe. The Company's first generation HearTwave System, CH 2000 Cardiac Stress Test System and the HearTwave II System have been approved for sale by the Japanese Ministry of Health Labor and Welfare.

The Company's 510(k) clearance allows the Company's MTWA Test to be used to test patients with known, suspected, or at risk of ventricular tachyarrhythmia and/or sudden cardiac arrest, and allows the claim that its MTWA Test is predictive of those events. The MTWA Module is designed to work with existing cardiac stress test platforms distributed by other manufacturers as an add-on module to enable MTWA testing to be performed using the Company's Micro-V Alternans Sensors.

The Company's HearTwave II System, which has replaced the Company's original HearTwave System, is used to perform both MTWA testing and standard cardiac stress testing. In addition to MTWA measurement, the Company's HearTwave II System is a cardiac diagnostic system designed to support a range of customized protocols for the conduct of cardiac exercise stress testing. The Comp! any's Micro-V Alternans Sensors are single patient use, multi-segment electrodes. The Company's CH2000 is a cardiac diagnostic system designed to support a range of customized protocols for the conduct and measurement of cardiac exercise stress testing.

The Company competes with GE Medical Systems.

Advisors' Opinion:
  • [By Peter Graham]

    Last Friday, small cap stocks Cambridge Heart, Inc (OTCMKTS: CAMH), Abby Inc (OTCMKTS: ABBY) and Grillit Inc (OTCMKTS: GRLT) surged 176.92%, 71.2% and 24.07%, respectively. Of course, that was last week and today is a new trading week. So what should investors and traders alike be prepared for this week with these three small caps? Here is a closer look to help you decide on an investing or trading strategy:

    Cambridge Heart, Inc (OTCMKTS: CAMH) Recently Changed Its Board

    Small cap Cambridge Heart, Inc is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. On Friday, Cambridge Heart, Inc surged 176.92% to $0.018 for a market cap of $1.80 million plus CAMH is up 20% since the start of the year and down 86.1% over the past five years according to Google Finance.

Hot Long Term Companies To Buy Right Now: Alcobra Ltd (ADHD)

Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies. Advisors' Opinion:
  • [By Roberto Pedone]

    A biopharmaceutical stock that's starting to trend within range of triggering a big breakout trade is Alcobra (ADHD), which is engaged in the development and commercialization of its proprietary drug, MG01CI, to treat attention deficit hyperactivity disorder. This stock has been on fire so far in 2013, with shares up huge by 126%.

    If you take a look at the chart for Alcobra, you'll notice that this stock has been trending sideways and consolidating over the last month and change, with shares moving between $14.78 on the downside and $18.75 on the upside. Shares of ADHD have now started to uptrend a bit over the last few weeks, with shares moving higher from its low of $15.05 to its recent high of $18.45 share. That move has started to push shares of ADHD within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.

    Traders should now look for long-biased trades in ADHD if it manages to break out above its 50-day moving average of $17.79 a share, and then once it takes out some more key overhead resistance levels at $18.45 to $18.75 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 74,869 shares. If that breakout triggers soon, then ADHD will set up to re-test or possibly take out its next major overhead resistance levels at $22 to $24 a share. Any high-volume move above those levels will then give ADHD a chance to re-test or possibly take out its all-time high at $26.96 a share.

    Traders can look to buy ADHD off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support levels at $16.17 to $15.05 a share, or around $14.78 a share. One could also buy ADHD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By MONEYMORNING.COM]

    For example, a phase 3 clinical trial on metadoxine extended release as a treatment for adult attention deficit hyperactivity disorder (ADHD) will be finishing up at the end of this year. Positive data could give the stock a huge boost.

Hot Long Term Companies To Buy Right Now: Booz Allen Hamilton Holding Corp (BAH)

Booz Allen Hamilton Holding Corporation (Booz Allen Holding), incorporated in May 2008, is a provider of management and technology consulting services to the United States government in the defense, intelligence and civil markets. In addition, it provides management and technology consulting services to corporations, institutions, and not-for-profit organizations. During the fiscal year ended March 31, 2012 (fiscal 2012), it derived 98% of its revenue from services provided to more than 1,200 client organizations across the United States government under more than 5,800 contracts and task orders. During fiscal 2012, it derived 90% of its revenue in fiscal 2012 from engagements, for which it acted as the prime contractor. On November 30, 2012, the Company purchased the Defense Systems Engineering and Support (DSES) division of ARINC Incorporated.

Defense Clients

During fiscal 2012, the Company�� defense business revenue represented 53% of its business. It works with its the United States Army clients to help sustain their land combat capabilities while responding to current demands and preparing for future needs. The services, which it provided include enhancing field intelligence systems, delivering rapid response solutions to counter improvised explosive devices, infusing lifecycle sustainment capabilities to improve distribution and delivery of material, and employing systems and consulting methods to help expand care and support for soldiers and their families. Its clients include Army Headquarters, Army Material Command (AMC), Forces Command (FORSCOM), Training and Doctrine Command (TRADOC), and Program Executive Offices, Direct Reporting Units and Army Service Component Commands.

The Company employs a multidimensional approach, which analyzes and balances people, processes, technology, and infrastructure to meet their missions of equipping global forces. Its clients include the Office of the Secretary of the Navy, Chief of Naval Operations, the Commandant ! of the Marine Corps to the Office of Naval Intelligence, and the United States Navy/Marine Corps operating commands and systems commands, as well as the Joint Program Executive Offices (PEO) and individual PEOs, such as Naval Air Systems Command (NAVAIR), Naval Seas Systems Command (NAVSEA), United States Marine Corps Systems Command, and Space and Naval Warfare (SPAWAR).

The Company provides integrated strategy and technical services to the United States Air Force. It brings capabilities to assignments, which includes weapons analysis, capability-based planning, and aircraft systems engineering. It also supports the space industry. Its clients include Air Combat Command, Air Force Space Command, Air Force Materiel Command, Air Mobility Command, Air Force Cyber Command, Air Force Pacific Command and National Aeronautics and Space Administration (NASA).

The Company provides mission-critical support to the Office of the Secretary of Defense, the Joint Staff, the Combatant Commands (COCOMs), and other the United States government departments and agencies during the planning and mission execution phases. Its clients include organizations within the Office of the Secretary of Defense and the Department of Defense�� agencies, as well as the Pacific Command, Northern Command, Central Command, the Defense Information Systems Agency (DISA), Southern Command, European Command, Strategic Command, Special Operations Command, and Transportation Command.

The Company provides solutions designed to protect infrastructure systems for the public and private sector to its United States government defense and intelligence agency clients to meet cyber warfare threats. Its cyber professionals handles the sensitive materials, assist clients in all phases of cyber-security operations and dynamic network defense. It develops cyber-security solutions utilizing a multi-dimensional approach, including people, operations, technology, policy, and management.

Intelligence Clients

The Company provides the primary group of government agencies and organizations, which carry out intelligence activities for the United States government (the United States Intelligence Community), with consulting and mission support services in analysis, systems engineering, program management, operations, organization, and change management, budget and resource management, studies, and war-gaming. During fiscal 2012, its intelligence business represented 23% of its business based on revenue. Its intelligence clients include United States Intelligence Agencies, Joint Staff and Unified Combatant Commands, and Military Intelligence.

The Company provides critical support in strategic planning, policy development, program development and execution, information sharing, architecture, and program management for research and development projects, as well as support to reform initiatives flowing from the Intelligence Reform and Terrorism Protection Act. It delivers intelligence analysis, including providing all-source intelligence analysis and open-source intelligence analysis. It also provides data collection management and analytical systems intelligence training services, and provides intellectual capital for intelligence activities. It provides consulting services, integrated intelligence and information operations mission support, and a range of counterintelligence services to the United States Army, United States Air Force, United States Navy, Marine Corps, and Defense Intelligence Agency.

Civil Clients

During fiscal 2012, the Company�� civil business represented 24% of its business based on revenue. Its civil government clients include Financial Services, Health, Energy, Transportation and Environment, Justice and Homeland Security, and Business of Government. The Company provides support to the United States government finance and treasury organizations charged with the collection, management, and protection of the United States financial system, including ! the Depar! tment of the Treasury, Internal Revenue Service, and other agencies of the Department of the Treasury, Office of the Comptroller of the Currency, Federal Deposit Insurance Corporation, Federal Reserve Board and Banks, the Securities and Exchange Commission (SEC), and Pension Benefit Guaranty Corporation. It creates approaches to challenging problems, including bank receivership, payment channel modernization, cyber initiatives, and fraud detection.

The Company supports United States government clients on projects, which helps to achieve public health missions, including entitlement reform, developing a national health information network, mitigating risk to populations, improving government infrastructure, and facilitating an international public-private sector dialogue on international health issues. Its clients include the Department of Health and Human Services and its agencies, including the United States Food and Drug Administration, National Institutes of Health, Centers for Disease Control and Prevention (CDC), the Centers for Medicare and Medicaid Services, the Department of Defense Military Health System, and Department of Veterans Affairs.

The Company supports clients in the transportation, energy, and environment sectors which controls over its national infrastructure. Its services include strategy, operations, technology, and engineering. Its clients include the Departments of Energy, Transportation, and Interior and their component agencies, and the Environmental Protection Agency. It also supports the Department of Defense in environmental and infrastructure programs in the United States and Europe. The Company supports the United States government�� homeland security mission and operations in the areas of intelligence (analysis, information sharing, and risk assessment), operations (coordination, contingency planning, and decision support), strategy, technology and management (program management and information technology tools), emergency management and respo! nse plann! ing, and border, cargo, and transportation security. It supports law enforcement missions and operations in counterterrorism, intelligence and counterintelligence, and criminal areas (narcotics, white collar crime, organized crime, and violent crime).

The Company helps agencies manage the business processes, which support government in its provision of services to its citizens, spanning management, personnel, budget operations, information technology, and telecommunications. Its clients include the General Services Administration, Office of Management and Budget, Office of Personnel Management, the Congress and Courts. It also support public sector grant-making agencies, from health and education, to labor and homeland and economic security, serving clients, such as the Departments of Agriculture, Homeland Security, Commerce, Education, Labor, and Housing and Urban Development, as well as the National Science Foundation. In addition, it serves the United States government clients abroad in helping them resolve systemic global development needs. Its clients include the United States Agency for International Development, the Department of State, Millennium Challenge Corporation, and the World Bank.

Commercial and International Clients

The Company is serving industries, such as financial services, healthcare, and energy. Its service offerings to commercial clients include dynamic defense (cyber), next-generation virtual infrastructure, decision analytics, design for affordability, and smart compliance. Its commercial clients include major commercial banks and investment banks, healthcare providers, energy companies, and utilities. Its international activities are focused on the Middle East and North Africa region. Its service offerings to international clients focuses on on-line government services and cloud applications, enterprise resource planning, advanced persistent threat resolution, supervisory control and data acquisition, and geospatial systems. Its internati! onal clie! nts include government ministries and commercial companies in the Middle East and North Africa.

The Company competes with CACI International, Inc., L-3 Communications Holdings, Inc., ManTech International Corp., SRA International, Inc., TASC Inc., General Dynamics Corp., Lockheed Martin Corp., Northrop Grumman Corp., Raytheon Co., Accenture, Computer Sciences Corp., Deloitte Consulting LLP and SAIC, Inc.

Advisors' Opinion:
  • [By Rich Smith]

    The biggest of these contracts, a sizable $179.9 million, one-year award with the potential to swell to $899.5 million if the four "option-year" extensions are exercised, is to be split among 13 separate firms:

    Booz Allen Hamilton (NYSE: BAH  ) CACI (NYSE: CACI  ) Technologies Computer Sciences Corp (NYSE: CSC  ) General Dynamics (NYSE: GD  ) One Source Honeywell (NYSE: HON  ) Technology Solutions Engility Corp. Lockheed Martin Science Applications International Corp. URS Federal Services and four privately held firms.

    Under the awarded indefinite-delivery/indefinite-quantity (IDIQ), cost-plus-fixed-fee, performance-based umbrella contract, all 13 firms will be able to compete to perform task orders for the U.S. Navy, providing "integrated cyber operations services" to Space and Naval Warfare Systems Center Atlantic.

  • [By Rich Smith]

    As already mentioned, 30 contractors are named as recipients, from well-known contractor names such as Booz Allen Hamilton (NYSE: BAH  ) , General Dynamics (NYSE: GD  ) , Honeywell (NYSE: HON  ) , Lockheed Martin (NYSE: LMT  ) , and Raytheon (NYSE: RTN  ) , all the way down to small businesses with names like PrimeTech International, Metrostar Systems, and Tatitlek Training Services. It is divided into three groupings, with some of the work reserved for section 8(a) Small Businesses and other work only for Reserved Small Business. But the majority of the work is considered "unrestricted," and up for bidding by 19 of the 30 firms named.

  • [By Maria Armental and Tess Stynes var popups = dojo.query(".socialByline .popC"); ]

    Booz Allen Hamilton Holding Corp.(BAH) said its fiscal fourth-quarter earnings declined 14% as the consulting company reported weaker revenue amid uncertainties about government spending. Still, adjusted earnings beat expectations.

  • [By Sean Williams]

    Another beneficiary has been advisory firms like Booz Allen Hamilton (NYSE: BAH  ) which, based on the GAO's release, had been granted close to $38 million in contracts for consulting and technical advisory services as of March. Helping out the technical teams with everything from oversight and eligibility to the actual support and integration of all of this technology, Booz Allen Hamilton's reputation has a lot riding on a successful launch.�

Hot Long Term Companies To Buy Right Now: Arena Pharmaceuticals Inc.(ARNA)

Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company?s clinical development programs include lorcaserin that has completed two pivotal Phase III clinical trials for the treatment of weight management, including weight loss and maintenance of weight loss; and APD811, which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension. Its preclinical development programs include APD334, for the treatment of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. The company also researches and develops cannabinoid, receptor agonists for the treatment of osteoarthritis and pain; and GPR119 agonists for the treatment of type 2 diabetes. Its other development programs, which had completed Phase I clinical trial include APD597 for th e treatment of type II diabetes; APD916 for the treatment of narcolepsy and cataplexy; and APD791 for the treatment of arterial thrombosis. In addition, the company provides manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Advisors' Opinion:
  • [By Sean Williams]

    Arena Pharmaceuticals (NASDAQ: ARNA  ) didn't have nearly as rough a go of things, but it certainly didn't have a good week, either. Following a first-quarter report that saw the company drastically miss the Street's revenue and profit estimates as it continues to wait for the final labeling of its chronic weight management drug, Belviq, from the Drug Enforcement Agency, Arena also announced it was pulling its EU marketing application for Belviq. The move isn't a complete shock given that VIVUS'�Qsymia failed to gain approval in Europe as well because of safety concerns, but it certainly takes any chance of garnering any EU revenue off the table for both companies, at least in the interim.

  • [By Brian Orelli]

    After getting rejected once, Arena Pharmaceuticals' (NASDAQ: ARNA  ) Belviq and VIVUS'� (NASDAQ: VVUS  ) Qsymia were both approved by the FDA last year. And the FDA seems open to approving a third drug, Orexigen's (NASDAQ: OREX  ) Contrave.

  • [By Brian Orelli]

    Observe the peaks in July 2012 after the FDA approved VIVUS'� (NASDAQ: VVUS  ) and Arena Pharmaceuticals' (NASDAQ: ARNA  ) obesity drugs. VIVUS launched Qsymia a few months later to lackluster sales. Arena's Belviq was just launched earlier this month after waiting for the DEA to sign off on the drug's scheduling. While Arena sits a little lower than its post-approval high, it still has a ways to fall if the drug also fails to meet investors' expectations.

  • [By James Brumley]

    Think Arena Pharmaceuticals (ARNA) and VIVUS (VVUS) used up all weight loss drug enthusiasm when the two companies won approval for Belviq and Qsymia, respectively, back in 2012?

Hot Long Term Companies To Buy Right Now: Meadwestvaco Corporation (MWV)

MeadWestvaco Corporation (MWV) provides packaging solutions to the healthcare, personal care and beauty, food, beverage, home and garden, tobacco, and commercial print industries worldwide. The company?s Packaging Resources segment produces bleached paperboard, Coated Natural Kraft paperboard, and linerboard. Its Consumer Solutions segment designs and produces multi-pack cartons and packaging systems primarily for the beverage take-home and tobacco market. In addition, it offers a range of converting and consumer packaging solutions, including printed plastic packaging and injection-molded products used for personal care, beauty, and pharmaceutical products; and dispensing and sprayer systems for personal care, beauty, healthcare, fragrance, and home and garden markets. In addition, this segment has a pharmaceutical packaging contract with a mass-merchant, and manufactures equipment that is leased or sold to its beverage and dairy customers to package their products. The c ompany?s Consumer & Office Products segment manufactures, sources, markets, and distributes school and office products, time-management products, and envelopes in North America and Brazil through both retail and commercial channels. Its Specialty Chemicals segment manufactures, markets, and distributes specialty chemicals derived from sawdust and other byproducts of the papermaking process in North America, South America, and Asia. Its products include activated carbon used in emission control systems for automobiles and trucks, as well as for water and food purification applications, and performance chemicals used in printing inks, asphalt paving, adhesives, and lubricants for the agricultural, paper, and petroleum industries. MWV?s Community Development and Land Management segment involves in real estate development, forestry operations, and leasing activities. MeadWestvaco Corporation was founded in 1888 and is based in Glen Allen, Virginia.

Advisors' Opinion:
  • [By Ray Merola]

    International Paper Co Share Price versus Competitors RockTenn (RKT), MeadWestvaco Corp (MWV), Packaging Corporation of America (PKG), and S&P 500 (March 2009-to-date)

No comments:

Post a Comment